Shionogi, established in 1878, is dedicated to developing innovative treatments for global health challenges such as antimicrobial resistance and COVID-19. With a history of introducing novel antibiotics and advanced medications for HIV and influenza, the company continues to advance clinical programs in areas like Fragile X syndrome, acute ischemic stroke, metabolic disorders, and oncology. Driven by a commitment to patient impact, Shionogi fosters strategic partnerships with industry leaders to accelerate scientific advancements and deliver first-in-class therapies worldwide.
The Medical Science Liaison (MSL) is a field-based representative of the Medical Affairs Organization that supports and represents Shionogi Inc and its products with, and to, key opinion leaders (KOLs), clinicians, institutions, and professional organizations. The incumbent addresses the specific needs of healthcare professionals (HCPs) by responding to unsolicited requests for information about our marketed and developing products. The ideal candidate will be based in Chicago or the surrounding suburbs to ensure effective coverage of the territory.
Shionogi, established in 1878, is dedicated to developing innovative treatments for global health challenges such as antimicrobial resistance and COVID-19. With a history of introducing novel antibiotics and advanced medications for HIV and influenza, the company continues to advance clinical programs in areas like Fragile X syndrome, acute ischemic stroke, metabolic disorders, and oncology. Driven by a commitment to patient impact, Shionogi fosters strategic partnerships with industry leaders to accelerate scientific advancements and deliver first-in-class therapies worldwide.
Shionogi